Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

75.74
-0.8600-1.12%
Volume:390.44K
Turnover:29.49M
Market Cap:14.83B
PE:-21.22
High:76.77
Open:76.20
Low:75.03
Close:76.60
52wk High:93.42
52wk Low:48.78
Shares:195.81M
Float Shares:167.00M
Volume Ratio:0.85
T/O Rate:0.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5686
EPS(LYR):-3.7850
ROE:-1789.67%
ROA:-26.00%
PB:-5.90
PE(LYR):-20.01

Loading ...

BridgeBio Publishes Discover-ATTR Digital Registry Presentation on ATTR-CM Data Integration

Reuters
·
60 mins ago

BridgeBio Pharma Currently Down Eight Consecutive Days, on Pace for Record Losing Streak

Dow Jones
·
1 hour ago

Piper Sandler Reaffirms Their Buy Rating on BridgeBio Pharma (BBIO)

TIPRANKS
·
3 hours ago

BridgeBio Pharma presents new analyses from Phase 3 ATTRibute-CM study

TIPRANKS
·
19 hours ago

BridgeBio Pharma Doses First Patient in Trial Evaluating Long-Term Impact of Heart Disease Medicine

MT Newswires Live
·
Aug 26

BridgeBio Pharma doses first patient in ASCEND-ATTR trial

TIPRANKS
·
Aug 26

BridgeBio Announces First Participant Dosed in Ascend-Attr, a Phase 3B/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in Attr-Cm

THOMSON REUTERS
·
Aug 26

13D Filings

Dow Jones
·
Aug 22

BridgeBio Pharma CEO Neil Kumar Disposes of USD 3.07 Million in Common Shares

Reuters
·
Aug 21

BridgeBio Pharma's Transition to Rare Disease 'Commercial Powerhouse' On Track, RBC Says

MT Newswires Live
·
Aug 14

Analysts Are Bullish on Top Healthcare Stocks: BridgeBio Pharma (BBIO), Pyxis Oncology (PYXS)

TIPRANKS
·
Aug 14

BridgeBio Pharma, - Announces Pricing of 5,000,000 Share Secondary Offering by KKR Genetic Disorder L.p.

THOMSON REUTERS
·
Aug 14

BridgeBio Launches Secondary Offering of 5,000,000 Shares by KKR Genetic Disorder LP

Reuters
·
Aug 14

BridgeBio Pharma Announces Launch of Secondary Offering of Common Stock on Behalf of an Existing Shareholder

THOMSON REUTERS
·
Aug 14

Omeros Q2 Yartemlea Net Revenue Jumps 190%

Reuters
·
Aug 13

BridgeBio Pharma is Maintained at Buy by Truist Securities

Dow Jones
·
Aug 13

Liquidia Q2 Revenue Jumps on Yutrepia Sales

Reuters
·
Aug 12

U.S. Research Roundup-Cardinal Health, Lumentum Holdings, Public Storage

Reuters
·
Aug 12

BridgeBio Oncology Therapeutics Beri Opsi Saham 65.350 Lembar Kepada Dua Karyawan Baru Dengan Harga Pelaksanaan USD 9,28

Reuters
·
Aug 12

Bridgebio Pharma Reports Inducement Grants Under NASDAQ Listing Rule

Reuters
·
Aug 12